Marlborough, Mass. — Hologic, Inc. (Nasdaq: HOLX) is set to present groundbreaking new research on its AI-driven mammography technology this week at the Society of Breast Imaging (SBI) Annual Symposium in Colorado Springs, Colorado. The company’s showcase will include pivotal data from a Massachusetts General Hospital (MGH)-led study that evaluated the performance of Hologic’s Genius AI® Detection 2.0 mammography solution.
The retrospective study, conducted at MGH, analyzed 5,000 digital breast tomosynthesis (3D mammography) screening exams performed between 2016 and 2019. Researchers focused on two groups within the data: 100 cancer cases that were initially missed by radiologists but later confirmed to be malignant, and 500 cancers that were correctly identified by radiologists at the time of screening. The study evaluated Genius AI Detection 2.0’s ability to identify missed cancers and accurately localize those already detected.
Dr. Manisha Bahl, Breast Imaging Division Quality Director and Co-Service Chief at Massachusetts General Hospital, will present the findings. Bahl, who is also an Associate Professor of Radiology at Harvard Medical School, emphasized the potential of AI to enhance radiologists’ capabilities in breast cancer detection. Her presentation, titled “Artificial Intelligence (AI)-Based Computer-Assisted Detection and Diagnosis for Digital Breast Tomosynthesis (DBT): Characteristics of AI-Detected versus AI-Missed Breast Cancers,” is scheduled for 2:45 p.m. MT today in Broadmoor Hall C.
Beyond the research presentation, Hologic will spotlight several innovations at the symposium, including its contrast-enhanced mammography technology, the Envision™ Mammography Platform, and the newly launched Genius AI Detection PRO solution. This advanced platform is designed to improve cancer detection by analyzing prior exams and incorporating an AI assistant with automated reporting and workflow features. A key element of Genius AI Detection PRO is its red-yellow-green color-coded system, which indicates the AI’s confidence level regarding cancer presence, streamlining radiologists’ reading process. The solution has been shown to reduce reading time by up to 24%.
Hologic will also conduct multiple educational sessions at SBI. These include hands-on learning labs about contrast-enhanced mammography, held today at 1:30 p.m., 2:45 p.m., and 4 p.m. MT, and a lunch-and-learn session on April 25 at 12:15 p.m. MT focused on AI’s role in enhancing mammography accuracy and early cancer detection.
Mark Horvath, President of Breast and Skeletal Health Solutions at Hologic, highlighted the company’s commitment to advancing breast health. “It’s an exciting time for breast health innovation, and we’re proud to showcase our latest advancements at this year’s SBI event,” Horvath said. “From AI-driven solutions to breast surgery technologies, Hologic continues to lead the way in redefining the breast health continuum and improving the standard of care for women everywhere.”
